Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS)

CNY 43.7

(-3.02%)

EBITDA Summary of Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd.'s latest annual EBITDA in 2023 was 250.5 Million CNY , up 30.38% from previous year.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd.'s latest quarterly EBITDA in 2024 Q2 was 100.1 Million CNY , up 29.31% from previous quarter.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported an annual EBITDA of 231.85 Million CNY in 2022, up 44.18% from previous year.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported an annual EBITDA of 159.09 Million CNY in 2021, up 71.41% from previous year.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported a quarterly EBITDA of 91.52 Million CNY for 2024 Q1, up 156.3% from previous quarter.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported a quarterly EBITDA of 69.49 Million CNY for 2024 Q3, down -31.49% from previous quarter.

Annual EBITDA Chart of Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (2023 - 2017)

Historical Annual EBITDA of Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (2023 - 2017)

Year EBITDA EBITDA Growth
2023 250.5 Million CNY 30.38%
2022 231.85 Million CNY 44.18%
2021 159.09 Million CNY 71.41%
2020 93.77 Million CNY 58.13%
2019 65.75 Million CNY 75.07%
2018 30.68 Million CNY 520.55%
2017 4.22 Million CNY 0.0%

Peer EBITDA Comparison of Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

Name EBITDA EBITDA Difference
Jiang Zhong Pharmaceutical Co.,Ltd 1.03 Billion CNY 75.684%
Zhejiang Shengda Bio-Pharm Co., Ltd. 34.44 Million CNY -627.173%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 111.25 Million CNY -125.166%
Nanjing Well Pharmaceutical Group Co.,Ltd. 209.72 Million CNY -19.445%
Ningbo Menovo Pharmaceutical Co., Ltd. 155.45 Million CNY -61.147%
Lionco Pharmaceutical Group Co.,Ltd. -90.79 Million CNY 375.915%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd -57.84 Million CNY 533.066%
ChengDu ShengNuo Biotec Co.,Ltd. 121.76 Million CNY -105.736%
Shanghai Haoyuan Chemexpress Co., Ltd. 275.11 Million CNY 8.946%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 971.82 Million CNY 74.223%
Yabao Pharmaceutical Group Co., Ltd 391.76 Million CNY 36.057%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.97 Billion CNY 87.337%
Hubei Jumpcan Pharmaceutical Co., Ltd. 3.61 Billion CNY 93.075%
Zhongzhu Healthcare Holding Co.,Ltd -234.13 Million CNY 206.993%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 3.22 Million CNY -7656.001%
Tibet Weixinkang Medicine Co., Ltd. 266.6 Million CNY 6.039%
Shandong Buchang Pharmaceuticals Co., Ltd. 1.09 Billion CNY 77.148%
Shenzhen Chipscreen Biosciences Co., Ltd. 187.43 Million CNY -33.645%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 265.55 Million CNY 5.667%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 267.44 Million CNY 6.334%
KPC Pharmaceuticals, Inc. 801.81 Million CNY 68.758%
Shanghai Jiaoda Onlly Co.,Ltd 17.57 Million CNY -1325.069%
Hunan Fangsheng Pharmaceutical Co., Ltd. 310.08 Million CNY 19.215%
Guobang Pharma Ltd. 1.04 Billion CNY 75.945%
Shanghai Yizhong Pharmaceutical Co., Ltd. 195.4 Million CNY -28.2%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 479.02 Million CNY 47.705%
Harbin Pharmaceutical Group Co., Ltd. 1.02 Billion CNY 75.546%
Beijing Tongrentang Co., Ltd 4.09 Billion CNY 93.887%
Henan Lingrui Pharmaceutical Co., Ltd. 736.53 Million CNY 65.989%
Tasly Pharmaceutical Group Co., Ltd 1.95 Billion CNY 87.183%
Kangmei Pharmaceutical Co., Ltd. 536.71 Million CNY 53.327%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 840.85 Million CNY 70.209%
Humanwell Healthcare (Group) Co.,Ltd. 4.55 Billion CNY 94.505%
China Animal Husbandry Industry Co., Ltd. 677.63 Million CNY 63.033%
Ginwa Enterprise (Group) Inc. -3.67 Million CNY 6916.01%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 565.74 Million CNY 55.721%
Mayinglong Pharmaceutical Group Co., LTD. 633.25 Million CNY 60.442%
Henan Taloph Pharmaceutical Stock Co.,Ltd 111.8 Million CNY -124.048%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 1.59 Billion CNY 84.317%
Dali Pharmaceuticalco.,Ltd 360.83 Thousand CNY -69324.433%
Shandong Lukang Pharmaceutical Co.,Ltd. 741.88 Million CNY 66.234%
HPGC Renmintongtai Pharmaceutical Corporation 474.3 Million CNY 47.185%
Changchun BCHT Biotechnology Co. 662.93 Million CNY 62.213%
Zhejiang Medicine Co., Ltd. 1.13 Billion CNY 77.954%
Zhejiang Huahai Pharmaceutical Co., Ltd. 2.15 Billion CNY 88.378%
Jianmin Pharmaceutical Group Co.,Ltd. 615.11 Million CNY 59.275%
CanSino Biologics Inc. -1.64 Billion CNY 115.212%
Sichuan Huiyu Pharmaceutical Co., Ltd. 203.49 Million CNY -23.1%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 743.16 Million CNY 66.292%
Hunan Warrant Pharmaceutical Co.,Ltd 292.03 Million CNY 14.222%
Guizhou Yibai Pharmaceutical Co., Ltd. 355.07 Million CNY 29.45%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 348.84 Million CNY 28.191%
Joincare Pharmaceutical Group Industry Co.,Ltd. 5.01 Billion CNY 95.003%
North China Pharmaceutical Company Ltd. 1.51 Billion CNY 83.493%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 2.21 Billion CNY 88.714%
Zhejiang Hisun Pharmaceutical Co., Ltd. 1.18 Billion CNY 78.776%
Chongqing Taiji Industry(Group) Co.,Ltd 1.6 Billion CNY 84.364%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 6.45 Billion CNY 96.121%
China National Medicines Corporation Ltd. 2.82 Billion CNY 91.135%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 186.48 Million CNY -34.326%
Cisen Pharmaceutical Co., Ltd. 840.03 Million CNY 70.179%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 5.55 Billion CNY 95.494%
Zhejiang Starry Pharmaceutical Co.,Ltd. 327.5 Million CNY 23.512%
Tibet Rhodiola Pharmaceutical Holding Co. 976.16 Million CNY 74.338%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 259.87 Million CNY 3.607%